Our Services
Corporate Communications
Designing, implementing and effectively operating international Corporate Communications programs is part of our core expertise.
Investor Relations
Our trained senior Investor Relations specialists provide a unique opportunity to have immediate access to the necessary tools, skills and networks you need in Europe, the UK and the US.
Roadshows & Transactions
Product & Science PR
Right from its scientific beginnings, and all the way through regulatory approval and market launch we support the strategic positioning and marketing of your product – and the science behind it – to the relevant stakeholders.
MC Services is Supporting Partner for LSX World Congress USA
We are proud to support again this year LSX World Congress USA, taking place on September 23-24, 2026 in Boston, MA, as part of Biotech Week Boston.
Built around the theme “Powering Biotech Growth Through Capital and Pharma Partnerships,” the event gathers 1000+ leaders from the US biotech, medtech, and pharmatech sectors to network, showcase innovations, and explore partnership and scout high-growth opportunities.
MC Services is media partner for LSI Europe ’26 Medtech & Healthtech Summit
Now in its fifth year, LSI Europe has become a “must attend” event for the global medtech and healthtech community. LSI Europe ’26 in Barcelona will bring together 1,000+ delegates to foster meaningful connections amongst startups, industry leaders, strategics, and investors.
Join us September 28 – October 1, 2026, at the Grand Hyatt Barcelona, Spain.
MC Services is media partner for BIO-Europe 2026
MC Services is proud to once again support BIO-Europe as official media partner. Taking place from November 9–11, 2026, in Cologne, Germany, BIO-Europe is the global strategic biopharma platform where senior industry leaders connect, align on priorities, and advance partnerships.
The 2026 edition will bring together more than 5,800 participants from over 3,200 companies across more than 60 countries, including biotech and pharma executives, investors and strategic partners. While partnering remains central, the program will also address broader industry priorities, from investment and dealmaking to clinical, regulatory and manufacturing strategy.
For more information on the program, timing and additional activities, please visit the event’s website.